144 related articles for article (PubMed ID: 6819454)
1. Modulation of the plasminogen activator activity of a transformed cell line by cell density.
Liu HY; Peltz SW; Mangel WF
Mol Cell Biol; 1982 Nov; 2(11):1410-6. PubMed ID: 6819454
[TBL] [Abstract][Full Text] [Related]
2. Modulation of cell-associated plasminogen activator activity by cocultivation of a stem cell and its tumorigenic descendant.
Liu HY; Yang PP; Toledo DL; Mangel WF
Mol Cell Biol; 1984 Jan; 4(1):160-5. PubMed ID: 6538259
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells.
Crutchley DJ; Conanan LB
J Biol Chem; 1986 Jan; 261(1):154-9. PubMed ID: 3079753
[TBL] [Abstract][Full Text] [Related]
4. New assay for the plasminogen activator activity of transformed cells.
Mangel WF; Livingston DC; Brocklehurst JR; Liu HY; Peltz GA; Cannon JF; Leytus SP; Wehrly JA; Salter BL; Mosher JL
Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 1,():669-80. PubMed ID: 6448727
[No Abstract] [Full Text] [Related]
5. Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells.
Coleman PL; Patel PD; Cwikel BJ; Rafferty UM; Sznycer-Laszuk R; Gelehrter TD
J Biol Chem; 1986 Mar; 261(9):4352-7. PubMed ID: 2936742
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions.
Chmielewska J; Rånby M; Wiman B
Biochem J; 1988 Apr; 251(2):327-32. PubMed ID: 3135797
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.
Ellis V; Wun TC; Behrendt N; Rønne E; Danø K
J Biol Chem; 1990 Jun; 265(17):9904-8. PubMed ID: 2161846
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells.
Seifert SC; Gelehrter TD
Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6130-3. PubMed ID: 104300
[TBL] [Abstract][Full Text] [Related]
9. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
Cubellis MV; Andreasen P; Ragno P; Mayer M; Danø K; Blasi F
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4828-32. PubMed ID: 2544876
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.
Boxman IL; Quax PH; Löwik CW; Papapoulos SE; Verheijen J; Ponec M
J Invest Dermatol; 1995 Mar; 104(3):374-8. PubMed ID: 7861005
[TBL] [Abstract][Full Text] [Related]
11. Differences in intracellular distribution of plasminogen activator in growing, confluent, and transformed 3T3 cells.
Jaken S; Black PH
Proc Natl Acad Sci U S A; 1979 Jan; 76(1):246-50. PubMed ID: 284339
[TBL] [Abstract][Full Text] [Related]
12. Cell density-dependent secretion of plasminogen activator by 3T3 cells.
Chou IN; O'Donnell SP; Black PH; Roblin RO
J Cell Physiol; 1977 Apr; 91(1):31-7. PubMed ID: 404303
[TBL] [Abstract][Full Text] [Related]
13. Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation.
Cohen RL; Niclas J; Lee WM; Wun TC; Crowley CW; Levinson AD; Sadler JE; Shuman MA
J Biol Chem; 1989 May; 264(14):8375-83. PubMed ID: 2498314
[TBL] [Abstract][Full Text] [Related]
14. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
[TBL] [Abstract][Full Text] [Related]
15. Expression of the catalytic activity of plasminogen activator under physiologic conditions.
Aggeler J; Risch J; Werb Z
Biochim Biophys Acta; 1981 Jun; 675(1):62-8. PubMed ID: 6455162
[TBL] [Abstract][Full Text] [Related]
16. Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C.
Fay WP; Owen WG
Biochemistry; 1989 Jul; 28(14):5773-8. PubMed ID: 2505842
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of a plasminogen activator from oncogenic virus-transformed mouse cells by rabbit antibodies against the enzyme.
Danø K; Nielsen LS; Møller V; Engelhart M
Biochim Biophys Acta; 1980 Jun; 630(1):146-51. PubMed ID: 6248125
[TBL] [Abstract][Full Text] [Related]
18. Rapid purification of a high-affinity plasminogen activator from human blood plasma by specific adsorption on fibrin/Celite.
Husain SS; Lipinski B; Greuwich V
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4265-9. PubMed ID: 6270665
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator from cells transformed by an oncogenic virus: inhibitors of the activation reaction.
Danø K; Reich E
Biochim Biophys Acta; 1979 Jan; 566(1):138-51. PubMed ID: 215232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
